Trump Announces Chief Of Staff Susie Wiles Has Breast Cancer

President Donald Trump announced Monday that White House chief of staff Susie Wiles was diagnosed with early-stage breast cancer.

Trump stated on Truth Social that Wiles will continue to work while she undergoes treatment. She reportedly has an “excellent” prognosis and has decided to begin treatment immediately.

“Susie Wiles is an incredible Chief of Staff, a great person, and one of the strongest people I know but, unfortunately, she has been diagnosed with early stage breast cancer, and has decided to take on this challenge, IMMEDIATELY, as opposed to waiting. She has a fantastic medical team, and her prognosis is excellent!” Trump said. (RELATED: Susie Wiles Says Trump Will ‘Campaign Like IT’s 2024 Again’ For Midterms)

Trump also praised Wiles for being “tough and deeply committed to serving the American people” despite her current illness.

“During the treatment period, she will be spending virtually full time at the White House, which makes me, as President, very happy!” Trump continued. “Her Strength and her Commitment to continue doing the job she loves, and does so well, while undergoing treatment, tells you everything you need to know about her. Susie, as one of my closest and most important advisors, is tough and deeply committed to serving the American People. She will soon be better than ever!”

Wiles has been a close adviser to Trump since his 2016 campaign, when she ran the campaign’s operations in Florida. She also helped run Trump’s 2024 campaign nationally before assuming her current role as chief of staff. She is often credited with helping turn Florida, a former swing state, into a reliable win for Trump in the 2016, 2020 and 2024 elections.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].